ReviewDrug design, development and therapy2026
The Evolving Landscape of Hepatocellular Carcinoma Therapy: From Conventional Modalities to TME-Responsive Prodrug Design Strategies.
Jiayao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.